Should we embrace hypofractionated radiotherapy for cervical cancer? A technical note on management during the COVID-19 pandemic. (July 2020)

• Record Type: Journal Article
• Authors: Mendez, Lucas C.; Raziee, Hamid; Davidson, Melanie; Velker, Vikram; D'Souza, David; Barnes, Elizabeth; Leung, Eric
• Is Part Of: Radiotherapy and oncology. Volume 148(2020)
• Page Start: 270
• Page End: 273
• Publication Date: 2020-07
• Subjects: Covid-19 -- Radiotherapy -- Hypofractionation -- Cervical cancer; Oncology -- Periodicals; Radiotherapy -- Periodicals; Tumors -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- radiotherapy -- Periodicals; Radiotherapy -- Periodicals; Radiothérapie -- Périodiques; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Electronic journals; 616.9940642
• DOI: 10.1016/j.radonc.2020.05.032
• Languages: English
• ISSNs: 0167-8140

Abstract

Abstract: Cervical cancer is a deadly disease and the COVID-19 pandemic has the potential to further impact its lethality. Hypofractionated radiotherapy could mitigate this impact, however robust data in cervical cancer setting still is lacking. Information provided here could help institutions in reducing radiotherapy fractions for cervical cancer patients.